Home›Search›Cancer Chemotherapy and Pharmacology

Cancer Chemotherapy and Pharmacology

Springer Science and Business Media Deutschland GmbH · Germany · Est. 1977

ISSN1432-0843

SJR Q2✓ WOS SCIE✓ Scopus / SJR

/ 100

High Trust

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ WoS flagship (SCIE/SSCI/AHCI)78

✓ Corroboration (3 more)+18

Total96

Level data: Norwegian Register (HK-dir), NLOD 2.0. · Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

141

days submission → published

measured · last 19 articles · accept 120d

SJR Rank

Top 50% in field

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q2. Source: Clarivate Journal Citation Reports.

SJR Scorei

0.851

H-Indexi

153

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIPi

0.787

Total Worksi

9,829

Total Citationsi

273,142

2yr Mean Citednessi

1.95

Open Impact Factor alternative

Retractions

Source: Retraction Watch

Aims & Scope

Cancer Chemotherapy and Pharmacology reports preclinical and or clinical pharmacology of anticancer drugs, covering pharmacokinetics and pharmacodynamics aspects. The journal publishes results recorded in the following areas: - Pharmacokinetics - Pharmacodynamics - Drug interactions - Exposure response relationships - Predictors of response/toxicity

General Information

Country / RegionGermany

Primary LanguageEnglish

1st Year Published1977

FrequencyMonthly

StatusActive (last: 2026)

Total Publications9,829

Publisher OrgSpringer Science+Business Media

Visit Journal Website

Submission Info

Peer Review—

Review Time—

Acceptance Rate—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

6/12 · 50%

✅

Do you know the journal / publisher?

Springer Science and Business Media Deutschland GmbH

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1432-0843

✅

Indexed in a trusted database?

WoS, Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

252

5.6k

2019

184

3.1k

2020

173

2.6k

2021

125

1.3k

2022

126

939

2023

109

410

2024

113

186

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

OncologyQ2

PharmacologyQ2

Pharmacology (medical)Q2

ToxicologyQ2

Cancer ResearchQ3

Subject Classification

Web of Science Categories

OncologyPharmacology & Pharmacy

Scopus Categories

PharmacologyPharmacology (medical)Cancer ResearchOncologyToxicology

Research Topics (OpenAlex)

Cancer Treatment and PharmacologyCancer therapeutics and mechanismsColorectal Cancer Treatments and StudiesLung Cancer Research StudiesLung Cancer Treatments and MutationsChemotherapy-induced organ toxicity mitigationDrug Transport and Resistance MechanismsChemotherapy-induced cardiotoxicity and mitigationAcute Lymphoblastic Leukemia researchHER2/EGFR in Cancer Research

Frequently asked questions about Cancer Chemotherapy and Pharmacology

Is Cancer Chemotherapy and Pharmacology a predatory journal?

PubScope has no integrity flags on record for Cancer Chemotherapy and Pharmacology: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 96/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Cancer Chemotherapy and Pharmacology?

Cancer Chemotherapy and Pharmacology is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 1.95.

Is Cancer Chemotherapy and Pharmacology indexed in Scopus and Web of Science?

Cancer Chemotherapy and Pharmacology is indexed in Web of Science, Scopus.